Insider Transactions Reported by 21 Insiders of NKGen Biotech, Inc.

Location
Santa Ana, CA

Insiders trading volume in the past year

NKGen Biotech, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sangwoo Park Director, Other*, 10%+ Owner $34.6M 13 Dec 2023
Graf Acquisition Partners IV LLC 10%+ Owner $23M 20 Dec 2024
Paul Y. Song Chief Executive Officer $7.97M +$7.95M +36555% 05 May 2025
CFIC-2015 NV Family Investments, LLC 10%+ Owner $7.76M +$7.5M +2832% 27 May 2025
Yong Man Kim CSO and CIO $93.4K 12 Feb 2024
ALEXANDRA LEBENTHAL Director $65.8K 14 Jul 2021
Jeanne Manischewitz Director $65.8K 20 May 2021
Anatolio B. Cruz III Director $65.8K 20 May 2021
EDWIN RIGAUD Director $65.8K 20 May 2021
Gus Garcia Co-President, Director $4.94K 25 May 2021
Sterling Cross CFO and Treasurer 11 May 2022
Lewis Silberman Co-President, Director 20 May 2021
Anantha Ramamurti CFO and Treasurer 20 May 2021
Anthony A. Kuznik EVP, GC and Secretary 20 May 2021
Sabrina McKee EVP, Strategy 20 May 2021
Michael Klowden Director 06 Dec 2024
Pierre Gagnon Chief Operating Officer 12 Feb 2024
Marco Gottardis Director 11 Jul 2024
James Graf Chief Financial Officer 06 Dec 2024
Alana B. McNulty Director 29 Sep 2023
Kathleen Scott Director 06 Dec 2024

Recent Insider Transactions by Companies or Individuals for NKGen Biotech, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.